Dietary Amino Acids Impact LRRK2-Induced Neurodegeneration in Parkinson's Disease Models

Abstract

The G2019S mutation in leucine-rich repeat kinase 2 (LRRK2) is a common cause of Parkinson's disease (PD) and results in age-related dopamine neuron loss and locomotor dysfunction in Drosophila melanogaster through an aberrant increase in bulk neuronal protein synthesis. Under non-pathologic conditions, protein synthesis is tightly controlled by metabolic regulation. Whether nutritional and metabolic influences on protein synthesis can modulate the pathogenic effect of LRRK2 on protein synthesis and thereby impact neuronal loss is a key unresolved question. Here, we show that LRRK2 G2019S-induced neurodegeneration is critically dependent on dietary amino acid content. Low dietary amino acid concentration prevents aberrant protein synthesis and blocks LRRK2 G2019S-mediated neurodegeneration in Drosophila and rat primary neurons. Unexpectedly, a moderately high amino acid diet also blocks dopamine neuron loss and motor deficits in Drosophila through a separate mechanism involving stress-responsive activation of 5'-AMP-activated protein kinase (AMPK) and neuroprotective induction of autophagy, implicating the importance of protein homeostasis to neuronal viability. At the highest amino acid diet of the range tested, PD-related neurodegeneration occurs in an age-related manner, but is also observed in control strains, suggesting that it is independent of mutant LRRK2 expression. We propose that dietary influences on protein synthesis and autophagy are critical determinants of LRRK2 neurodegeneration, opening up possibilities for future therapeutic intervention.

Lactobacillus rhamnosus Probio-M9 Improves the Quality of Life in Stressed Adults by Gut Microbiota

“…Amino groups, primarily responsible for amino acid synthesis in organisms, are formed by glutamic acid and glutamine in the body. The increased amino acid content in the intestinal tract may inhibit neurological degeneration via stress response, such as alleviating Parkinson's phenotypes [40]. An experiment involving the effect of nicotine on the gutbrain axis in mice revealed that it caused changes in the gut microbiota and glutamate metabolism that affected the mice's gut-brain axis.…”

Unraveling Parkinson’s Disease Neurodegeneration: Does Aging Hold the Clues?

“…It remains to be determined whether TOR inhibition plays a role in the protective impact of AMPK activation, since autophagy can be induced via AMPK signaling which is a feasible mechanism. Work from our own laboratory indicates that LRRK2 G2019S expressing flies chronically fed a moderately elevated amino acid diet across adulthood are protected from age-related loss of dopamine neurons and locomotor dysfunction observed in these flies on a standard diet in a mechanism that involves induction of AMPK activity by the fly Sestrin ortholog and consequent upregulation of autophagy [ 165 ]. TOR inhibition may be neuroprotective in the context of LRRK2 G2019S, since enhanced vulnerability to valinomycin-induced cytotoxicity seen in LRRK2 G2019S iPSC-derived neural cells from familial PD patients can be attenuated by treating them with rapamycin [ 166 ] consistent with TOR involvement.…”

SREBP and central nervous system disorders: genetic overlaps revealed by in silico analysis

“…These stressors activate AMPK, which then phosphorylates α-synuclein, causing it to aggregate and eventually cause neurodegeneration [75]. In addition, reduced protein synthesis induced by AMPK activation could also cause neurodegeneration [111]. However, AMPK may also exert a neuroprotective effect by stimulating the destruction of damaged mitochondria and α-synuclein aggregates through autophagy [112,113].…”